Latest gene delivery Stories
PHILADELPHIA, June 2, 2014 /PRNewswire/ -- Spark Therapeutics, Inc., a late-stage gene therapy company developing treatments for a wide range of rare, debilitating diseases, announced today that company
Groundbreaking Nature Publication Describes Successful ZFN Driven Genome Editing in Long-Term Repopulating Stem Cells Necessary for Clinical Translation RICHMOND, Calif., May 28, 2014
Gene therapy leader to advance its deep pipeline of rare disease programs including its lead Phase 3 product candidate for RPE65-related blindness PHILADELPHIA, May 27, 2014 /PRNewswire/
SB-728-T-Treated Subject Maintains Control of Viral Load for 45 Weeks Without Anti-Retroviral Drugs RICHMOND, Calif., May 27, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
Transparency Market Research added a new report "Global Gene Therapy Market: Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store.
Researchers from Nexus Spine LLC and Brigham Young University have Developed New, High-Tech Device for Transferring DNA into Cells WASHINGTON, May 13, 2014 /PRNewswire-USNewswire/
Gene therapy leader will house business operations and manufacturing in a growing and dynamic biotech hub PHILADELPHIA, May 13, 2014 /PRNewswire/ --
DUBLIN, May 9, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3xg7sj/transfection)
TARRYTOWN, N.Y. and MENLO PARK, Calif., May 5, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
ALBANY, New York, April 24, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Transfection Technology Market (Reagent-based
- To swell, as grain or wood with water.